Advertisement
Advertisement
U.S. markets open in 2 hours 13 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Biotricity, Inc. (BTCY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3300+0.2100 (+18.75%)
At close: 04:00PM EDT
1.3300 0.00 (0.00%)
After hours: 06:25PM EDT
Advertisement

Biotricity, Inc.

275 Shoreline Drive
Suite 150
Redwood City, CA 94065
United States
650 832 1626
https://www.biotricity.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees44

Key Executives

NameTitlePayExercisedYear Born
Dr. Waqaas Al-Siddiq Ph.D.Founder, Pres, CEO & Chairman597kN/A1985
Mr. S. John AyanoglouChief Financial Officer228kN/A1966
Dr. George N. NikopoulosDirector of Bus. Devel.N/AN/AN/A
Mr. Amir AliChief Devel. OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biotricity, Inc., medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated electrocardiogram (ECG) device and software solution. The company is based in Redwood City, California.

Corporate Governance

Biotricity, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement